HUMAN MONOCLONAL ANTIBODY WITH SPECIFICITY FOR DENGUE VIRUS SEROTYPE 1 E PROTEIN AND USES THEREOF

• Main Authors: NG MAH LEE MARY, LOK SHEE MEI, MACARY PAUL ANTHONY, BRENDON JOHN HANSON, PETRA EVELIINA KUKKARO, EN WE TEO, LIM ANGELINE PEI CHIEW, EE PING EVELYN TEOH
• Format: Patent
• Language: English; Japanese
• Published: 29.03.2018
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; ORGANIC CHEMISTRY; PEPTIDES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

PROBLEM TO BE SOLVED: To provide compositions and methods for the treatment or prevention of dengue virus infection in a vertebrate subject.SOLUTION: Human neutralizing monoclonal antibodies disclosed herein are isolated from EBV immortalized B cells derived from patients who have recovered from den...